PODCAST
The Menopause Market Is Booming. Here's What's Actually Worth Your Money.
August 19, 2026·8:55·Episode 105
Quick Summary
JAMA takes a hard look at the exploding menopause care market and asks which treatments actually have evidence behind them. A new NAMS study finds that type 2 diabetes significantly worsens menopause symptoms — more than most people realize. And a peer-reviewed paper asks why clinicians almost never screen for intimate partner violence during menopause care visits.
The Menopause Market Is Booming. Here's What's Actually Worth Your Money.
0:000:00
Key Takeaways
- ✦The menopause care market is growing fast, but JAMA's review finds the evidence for many emerging treatments hasn't kept pace with the marketing.
- ✦Hormone therapy and a small number of non-hormonal options have the strongest research backing; most supplements and "menopause kits" do not.
- ✦A Korean study of midlife women found that those with type 2 diabetes reported significantly more menopause symptoms — and more severe ones — than women without diabetes.
- ✦Postmenopausal women with type 2 diabetes had a higher overall symptom burden, suggesting blood sugar management may directly affect quality of life during menopause.
- ✦Research published in the NAMS journal finds that clinicians rarely screen for intimate partner violence during menopause care visits, despite evidence that IPV affects both access to care and symptom severity.
Sources & References
Hot Flasher provides informational content only and does not constitute medical advice. Always consult a qualified healthcare provider for medical concerns.